CHO(E)P-14 Followed by Alemtuzumab Consolidation in Peripheral T Cell Lymphoma

Clinical trial NCT01806337 · COMPLETED

Trial details

NCT number: NCT01806337
Sponsor: University of Göttingen
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Peripheral T-Cell Lymphoma

Start date: 2003-07-01
Primary completion: 2006-07-01
Enrollment: 41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.